 | |
 | |
| Clinical data | |
|---|---|
| Other names | 5-MeO-DIBF; 5-MeO-DiPBF; 5-Methoxy-N,N-diisopropyl-3-(2-aminoethyl)benzofuran; 5-Methoxy-N,N-diisopropyl-benzofuranethylamine; 1-Oxa-5-MeO-DiPT |
| Routes of administration | Oral,insufflation[1] |
| Drug class | Serotonergic psychedelic;Hallucinogen |
| ATC code |
|
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Onset of action | 45 minutes[1] |
| Duration of action | 4–9 hours[1] |
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C17H25NO2 |
| Molar mass | 275.392 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
5-MeO-DiBF, also known as5-methoxy-N,N-diisopropyl-3-(2-aminoethyl)benzofuran or as1-oxa-5-MeO-DiPT, is apsychedelic drug of thebenzofuran family related to the psychedelictryptamine5-MeO-DiPT.[2][1][3] It is theanalogue andbioisostere of 5-MeO-DiPT in which theindolenitrogen has been replaced with anoxygenatom, making it a benzofuran rather than tryptamine.[2] The drug has been sold online as a noveldesigner drug starting in 2015.[1][4]
The dose of 5-MeO-DiBF has been given as 10 to 40 mgorally, with a light dose being 10 mg, a common dose being 20 mg, and a strong dose being 40 mg.[1] Itsonset is said to be 45 minutes and itsduration is variably said to be 4 to 9 hours.[1] In addition to oral administration, the drug may also beinsufflated.[1] The effects of 5-MeO-DiBF have been reported to includepsychedelic head space,tactile sensations andtingling, and increasedsexual desire, among others.[1]
Analogues of 5-MeO-DiBF have been found to interact withserotonin receptors including theserotonin5-HT1A and5-HT2 receptors.[5][6]
Analogues of 5-MeO-DiBF include thebenzofuransdimemebfe (5-MeO-BFE),MiPBF (1-oxa-MiPT),3-APB (1-oxa-AMT), andmebfap (5-MeO-3-APB; 1-oxa-5-MeO-AMT) and thetryptamine5-MeO-DiPT, among others.[3][2]
5-MeO-DiBF has been sold online as adesigner drug and was first definitively identified in December 2015 by a forensic laboratory inSlovenia.[1][4]
5-MeO-DiBF is not controlled under theUnited Nations1971 Convention on Psychotropic Substances, so thus it has a legal grey area in manycountries, but it's possible it could be illegal under so-called analogue acts if sold for human consumption.[citation needed]
The drug is acontrolled substance inArmenia as of 2022.[7]
5-MeO-DiBF is not acontrolled substance inCanada as of 2025.[8]
5-MeO-DiBF is not an explicitlycontrolled substance in theUnited States.[9] However, it could be considered a controlled substance under theFederal Analogue Act if intended for human consumption.
